Despite the limitations in our methodology, our study contributes to the hypothesis that IDH mutant Astrocytoma with Gemistocytic differentiation (IDH mutant GA) is an aggressive histological variant of IDH mutant Astrocytoma, is associated with an overall decreased survival time, and should be managed more aggressively. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).